20/20 BIOLABS, INC.: share_based_compensation

Value{"amount": 516180, "concept": "us-gaap:ShareBasedCompensation", "currency": "USD"}
Period2025-01-01 – 2025-12-31
Statuscurrent
Entity20/20 BIOLABS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-26-037667 · Open the official SEC filing →
Retrieved: 2026-08-19T11:27:01.038089+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001139685/share-based-compensation/2025-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/ee5ba9d4-d75a-4c71-b61e-c9ea5dad6f9c

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies